Sana Biotechnology Inc (SANA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sana Biotechnology Inc   (NASDAQ: SANA)


Sana Biotechnology Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sana Biotechnology Inc 's ROA in the second quarter of 2026?
Sana Biotechnology Inc recorded a cumulative net loss of $-212 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -46.12%.

However, within the Healthcare sector 570 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4039, from total ROA ranking in the first quarter of 2026 at 4686.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 69.03 % -16.14 % -6.51 % -12.88 % -35.09 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -212 -242 -244 -234 -252
Return On Assets (TTM) -46.12 % -60.97 % -58.86 % -55.53 % -57.55 %
SANA's Total Ranking # 4039 # 4686 # 4057 # 4114 # 4012
Total Assets (TTM) in million 611 374 417 435 362
Seq. Total Assets Change 63.63 % -10.39 % -4.26 % 20.4 % -18.82 %
Seq. Net Income Change - - - - -

SANA's 5 Years Annual ROA >> Back to SANA Management Effectiveness >> Compare SANA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 79
Sector # 571
Overall # 3904

Return On Assets Statistics
High Average Low
18.33 %
-37.05 %
-60.97 %
(Sep 30 2021)   (Mar 31 2026)





Financial Statements
Sana Biotechnology Inc 's Assets $ 611 million SANA's Balance sheet
Sana Biotechnology Inc 's Income $ -64 million Quarterly SANA's Income Statement
SANA's Income by Division See SANA's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -6.51 % -9.55 % -59.2 % 17.62 % -
Total Assets in million 417 446 493 1,208 1,027
Y / Y Net Income Change - - - - -
Net Income in million -244 -267 -283 -269 -356
Annual Return On Assets -58.57 % -59.82 % -57.45 % -22.3 % -34.65 %

SANA's 5 Years Annual ROA >> Back to SANA Management Effectiveness >> Compare SANA ROA to its Competitors



More Return On Assets Ratios
SANA's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SANA's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SANA's Competitors
Subscribers only: Roa for Sana Biotechnology Inc 's Suppliers
Subscribers only: Return On Assets for SANA's Customers

You may also want to know
SANA's Roi SANA's Inventory Turnover Ratio SANA's Growth Rates SANA's Dividend Comparisons
SANA's Profitability Ratios SANA's Asset Turnover Ratio SANA's Dividend Growth
SANA's Roe SANA's Valuation Ratios SANA's Financial Strength Ratios SANA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T22:09:54+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.